Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
|Hypercholesterolemia Medication Adherence||Behavioral: Medication adherence intervention Behavioral: Attention-control||Phase 1 Phase 2|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults|
- Medication adherence [ Time Frame: 6 months ]
- Serum cholesterol [ Time Frame: 6 months ]
|Study Start Date:||October 2010|
|Study Completion Date:||February 2014|
|Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Experimental: Medication adherence intervention
Receives 12-week behavioral feedback intervention to improve adherence to statin medication
Behavioral: Medication adherence intervention
12-week behavioral feedback intervention to improve adherence to statin medication
No Intervention: Control
Active Comparator: Attention-control
Receives visits on the same schedule as the intervention group, with health education that is unrelated to medications or cholesterol
Health education visits that are unrelated to medications or cholesterol, provided on the same visit schedule as the intervention group
This study will answer the following primary research question:
What is the estimated effect size of a behavioral MA intervention on MA rates in older adults who are poorly adherent to statin medications?
The study will also explore the following secondary research questions:
- What is the estimated effect size of a behavioral MA intervention on low-density lipoprotein cholesterol (LDL-C) levels in older adults?
- What is the estimated effect size of a behavioral MA intervention on high-density lipoprotein cholesterol (HDL-C) levels in older adults?
- What is the feasibility of successfully testing this intervention protocol in a population of older adults with low adherence to statin medications?
Please refer to this study by its ClinicalTrials.gov identifier: NCT01227330
|United States, Missouri|
|University of Missouri|
|Columbia, Missouri, United States, 65211|
|Principal Investigator:||Todd Ruppar, PhD, RN||University of Missouri-Columbia|